Skip to content
10-Q

Quarterly Report

BioPlus Acquisition Corp.

0001193125-23-145016

← back to feed
Filed
May 15, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Operating Cash Flow Q1 2023 · Mar 31, 2023 −$315.61K
Operating Cash Flow Q1 2023 · Mar 31, 2022 −$166.49K
Stockholders Equity Q1 2023 · Mar 31, 2023 −$15.05M
Stockholders Equity Q1 2023 · Dec 31, 2022 −$14.78M
Stockholders Equity Q1 2023 · Mar 31, 2022 −$13.86M
Stockholders Equity Q1 2023 · Dec 31, 2021 −$13.6M
Current Liabilities Q1 2023 · Mar 31, 2023 $700.53K
Current Liabilities Q1 2023 · Dec 31, 2022 $526.88K
Total Liabilities Q1 2023 · Mar 31, 2023 $15.5M
Total Liabilities Q1 2023 · Dec 31, 2022 $15.33M
Current Assets Q1 2023 · Mar 31, 2023 $447.14K
Current Assets Q1 2023 · Dec 31, 2022 $548.76K
Total Assets Q1 2023 · Mar 31, 2023 $240.82M
Total Assets Q1 2023 · Dec 31, 2022 $238.32M
Net Income Q1 2023 · Mar 31, 2023 $2.32M
Net Income Q1 2023 · Mar 31, 2022 −$261.82K
Operating Income Q1 2023 · Mar 31, 2023 −$275.27K
Operating Income Q1 2023 · Mar 31, 2022 −$307.19K